6-K
POMDOCTOR Ltd (POM)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of April 2026
Commission file number: 001-42749
POMDOCTOR LIMITED
Yongxu Industrial ParkNo.19-23 Hejing Road, Dongsha StreetLiwan District, Guangzhou 510000
People’s Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
INFORMATION CONTAINED IN THIS REPORT ON FORM6-K
Resignation of vice president
On March 31, 2026, Dexiang Wei resigned as Vice President of POMDOCTOR LIMITED (the “Company”), effective as of April 1, 2026. Mr. Wei’s resignation did not result from a disagreement with the Company’s Board of Directors on any matter relating to the Company’s operations, policies or practices. There are no matters relating to such resignation that need to be brought to the attention of the shareholders of the Company.
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| POMDOCTOR LIMITED |
|---|
| /s/ Zhenyang Shi |
| Zhenyang Shi |
| Chairman and Chief Executive Officer |
Date: April 8, 2026
2